Cresco Labs (CRLBF) Deferred Taxes (2020 - 2026)
Cresco Labs (CRLBF) reported Deferred Taxes of -$204000.0 for Q1 2026, up 56.87% on a YoY basis from -$130043.1 in Q1 2025, and up 94.73% quarter-over-quarter from -$3.9 million in Q4 2025.
Cresco Labs (CRLBF) Deferred Taxes (2020 - 2026) Analysis & Trends
Cresco Labs has reported Deferred Taxes for 7 years, with the latest figure at -$204000.0 in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 56.87% year-over-year to -$204000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.4 million (down 184.35% YoY), and the FY2025 full-year result was -$3.7 million, down 1898.06% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$204000.0, up from -$3.9 million in the prior quarter.
- The five-year high for Deferred Taxes was $4.4 million in Q4 2022, with the low at -$24.9 million in Q3 2023.
- Historically, Deferred Taxes has averaged -$2.4 million across 5 years, with a median of -$473000.0 in 2025.
- Annual changes were most pronounced in 2023 — Deferred Taxes slumped 374.52% — and 2024, when it surged 817.18%.
- Cresco Labs' Deferred Taxes stood at $4.4 million in 2022, then sank by 261.68% to -$7.1 million in 2023, then jumped by 54.42% to -$3.2 million in 2024, then dropped by 19.16% to -$3.9 million in 2025, then surged by 94.73% to -$204000.0 in 2026.
- The last three Deferred Taxes figures came in at -$204000.0 (Q1 2026), -$3.9 million (Q4 2025), and $305000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 19.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -13.98 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | -204,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -204,000.00 |
| Dec 31, 2025 | -3.87 Mn |
| Sep 30, 2025 | 305,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Mar 31, 2025 | -473,000.00 |
| Dec 31, 2024 | -3.25 Mn |
| Sep 30, 2024 | -479,000.00 |
| Jun 30, 2024 | 2.99 Mn |
| Mar 31, 2024 | 941,000.00 |
| Dec 31, 2023 | -7.12 Mn |
| Sep 30, 2023 | -24.88 Mn |
| Jun 30, 2023 | 326,000.00 |
| Mar 31, 2023 | -987,000.00 |
| Dec 31, 2022 | 4.41 Mn |
| Sep 30, 2022 | -7.17 Mn |
| Jun 30, 2022 | -1.68 Mn |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | 5.64 Mn |
| Sep 30, 2021 | -28.35 Mn |
| Jun 30, 2021 | -8.73 Mn |